U.S. federal trademark · Serial No. 88391716
Medicinal preparations consisting of proteins and nucleic acid sequences for diagnosis and treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; gene therapy and gene editing products, namely, therapeutic agents for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy and gene editing products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
Biological preparations, namely, proteins and nucleotide sequences for scientific and medical research
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.